> "In the first quarter, we launched our second Warrant Incentive
> Program to encourage the early exercise of approximately 73.9 million
> outstanding warrants. The program was successful as 42% of the
> warrants were exercised, generating net cash proceeds of $3.7
> million."

> The breakdown of those is as follows:

> As of March 31, 2009, the Company received proceeds of $2.2 million,
> net of professional fees of $0.1 million, from the exercise of 2.1
> million November 2004 Warrants, 0.7 million June 2006 Warrants and
> 16.1 million July 2007 Warrants under this program. Subsequent to the
> quarter, the Company received additional proceeds of $1.5 million from
> the exercise of 11.8 million warrants. Total proceeds received from
> the 2009 Warrant Incentive Program, net of professional fees were $3.7
> million.

> My take on what is happening now:

> The remaining July warrants are what have been holding this thing at
> the current  levels. They expire on July 13th although the majority of
> them have been excersiced over the past month or so according to my
> calculations. Some people think the price won't move above this flat-
> line we have seen as of late until the 13th.  I believe we will  start
> to see a little movement before then, albeit probably not a whole lot.
> After the 13th this thing will start to really take off IMO probably
> pushing the $1 mark just prior to the Aug 5th proposed decision date.

> Hope this helps.

> On Jul 1, 1:05 pm, "Paula&Max million" <1million2...@gmail.com> wrote:

> > "Mississauga, Ontario, Canada – January 6, 2009 - Nuvo Research Inc.
> > (TSX: NRI), a Canadian
> > drug development company focused on the research and development of
> > drug products delivered
> > to and through the skin using its topical and transdermal drug
> > delivery technologies, announced
> > today that the Toronto Stock Exchange (“TSX”) has approved a warrant
> > incentive program
> > designed to encourage the early exercise of 20,012,494 warrants (the
> > “November 2009 Warrants”),
> > 3,901,898 warrants (the “June 2009 Warrants”) and 50,000,000 warrants
> > (the “July 2009
> > Warrants”).
> > To the extent that holders of the warrants take advantage of the
> > opportunity, the early exercise of
> > the warrants will provide Nuvo with additional capital to continue to
> > execute its current business
> > plan. The proceeds of the early exercise will fund capital
> > requirements relating to the development
> > and commercialization of Nuvo’s pharmaceutical products, primarily its
> > Pennsaid® and Pennsaid
> > Plus® products, and for working capital and other corporate purposes.

> > The November 2009 Warrants were issued as part of a financing
> > completed in November 2004 and
> > can be exercised at $0.48 until November 16, 2009.

> > The June 2009 Warrants were issued as part of a financing completed in
> > June 2006 and can be
> > exercised at $0.50 until June 20, 2009.

> > The July 2009 Warrants were issued as part of a financing completed in
> > July 2007 and can be
> > exercised at $0.30 until July 13, 2009.

> > In order to encourage the early exercise of the warrants, Nuvo is
> > amending the November 2009
> > Warrants, the June 2009 Warrants and the July 2009 Warrants,
> > respectively, so that upon payment
> > of the applicable reduced exercise price of $0.125 (which represents
> > the volume weighted average
> > trading price of Nuvo common shares over the last five days) and
> > surrender of the holder’s warrant
> > in accordance with applicable procedures, the holder will be entitled
> > to receive one common share
> > of Nuvo.
> > Nuvo is providing the holders of November 2009 Warrants, June 2009
> > Warrants and July 2009
> > Warrants an exercise period commencing on January 21, 2009 and ending
> > at 5:00 p.m. (Toronto
> > time) on April 3, 2009 to exercise their warrants under the offer. If
> > a holder does not exercise his or
> > her warrants prior to April 3, 2009, the warrants will continue to be
> > exercisable for common shares
> > of Nuvo on the same terms as previously existed.
> > Insiders will not be eligible to participate in the warrant incentive
> > program.
> > The gross proceeds to Nuvo if all the November 2009 Warrants are
> > exchanged is $2.5 million. The
> > gross proceeds to Nuvo if all the June 2009 Warrants are exchanged is
> > $0.5 million. The gross
> > proceeds to Nuvo if all the July 2009 Warrants are exchanged is $6.2
> > million."

> > I know this is old news but I am interested in what you think the
> > warrants mean and how they affect the stock price.

> > Thanks.- Hide quoted text -

> - Show quoted text -